Intermediate hepatocellular carcinoma: the role of transarterial therapy.
about
68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat StudiesUpregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells.Hyaluronic acid-based nano-sized drug carrier-containing Gellan gum microspheres as potential multifunctional embolic agent.Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety.
P2860
Intermediate hepatocellular carcinoma: the role of transarterial therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intermediate hepatocellular carcinoma: the role of transarterial therapy.
@en
type
label
Intermediate hepatocellular carcinoma: the role of transarterial therapy.
@en
prefLabel
Intermediate hepatocellular carcinoma: the role of transarterial therapy.
@en
P2860
P50
P356
P1433
P1476
Intermediate hepatocellular carcinoma: the role of transarterial therapy
@en
P2093
Lorenzo Mannelli
Stefano Merolla
P2860
P304
P356
10.2217/HEP.15.32
P577
2015-10-01T00:00:00Z